Matrix Metalloproteinase 15 [matrixová metaloproteinasa 15]
- Terms
-
matrix metaloproteináza 15
matrixová metaloproteináza 15
matrixová metaloproteináza membránového typu 2
matrixová metaloproteináza MT2
metaloproteinasa MMP-15
metaloproteinasa MMP15
metaloproteináza MMP-15
metaloproteináza MMP15
MT2-MMP
-
Membrane-Type Matrix Metalloproteinase 2
Membrane-Type-2 Matrix Metalloproteinase
MMP-15 Metalloproteinase
MMP15 Metalloproteinase
MT2-Matrix Metalloproteinase
MT2-MMP
A transmembrane domain-containing matrix metalloproteinase that plays a role in the cleavage of proteins in the pericellular environment. It is synthesized as an inactive zymogen that is activated by the action of ENDOPEPTIDASES such as MATRIX METALLOPROTEINASE 14.
- DUI
- D053517 MeSH Browser
- CUI
- M0232699
- History note
- 2007(2005)
- Public note
- 2007; MATRIX METALLOPROTEINASE 15 was indexed under MATRIX METALLOPROTEINASES 2006 & under METALLOENDOPEPTIDASES 2005
Combination
- antagonists & inhibitors
- Matrix Metalloproteinase Inhibitors
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AN
- analysis 0
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 1
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 1
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0